Quadria Capital (Quadria), one of Asia’s largest healthcare-focused private equity firms, announced an investment of Rs. 850 crore in NephroPlus, Asia’s largest dialysis network. Through this ...
Lupin, the fifth largest pharma major in India, has posted strong performance during the fourth quarter ended March 2024 with higher revenues from US, growth markets and EMEA. The company’s ...
Novo Nordisk Foundation, Wellcome & The Gates Foundation join forces to accelerate global health equity and impact: Hellerup, Denmark Tuesday, May 7, 2024, 11:00 Hrs [IST] The Nov ...
IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson's disease, announced that the Swedish Medical Products Agency has approved the initiation of a phase I ...
AstraZeneca announced the successful completion of an equity investment with Cellectis, a clinical-stage biotechnology company. The equity investment and a research collaboration agreement, announced ...
Indian pharma adopts green initiatives with eco-friendly manufacturing processes to save environment
The Indian pharmaceutical industry is adopting green initiatives with eco-friendly manufacturing processes, renewable energy sources, optimizing packaging to minimize waste to mitigate its ...
In a bid to bolster clinical research efforts across India, the Indian Council of Medical Research (ICMR) has announced a call for expressions of interest (EOI) to expand the Indian Clinical Trial and ...
Peethaambaran Kunnathoor, Chennai Tuesday, May 7, 2024, 08:00 Hrs [IST] ...
DoP jointly with CII to organise India Meditech Stackathon on May 7: Our Bureau, New Delhi Tuesday, May 7, 2024, 08:00 Hrs [IST] The Department of Pharmaceuticals (DoP), in collab ...
The US-based drug major Pfizer has received a favourable order in a trademark litigation against a Homoeopathy drug firm in India in connection with its erectile dysfunction drug Viagra, ending an ...
The Pharmaceuticals Export Promotion Council of India (Pharmexcil)’s Director General Uday Bhaskar has urged member companies to follow revised guidance of the Drugs Controller General of India (DCGI) ...
The students and alumni of the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, have expressed concern over the discontinuation of MBA (Pharma) course at the prestigious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback